Efficacy of sGC activators in cancer is not well studied, although two preclinical studies suggest that sGC can mitigate platinum chemotherapeutic resistance in oropharyngeal squamous cell carcinoma [304,305]. This evidence concerns the gene SGCB and oropharynx squamous cell carcinoma.